Prospective Real-World Assessment of Pain Relief with Injection-Based Delivery of Etoricoxib (RAPID Study) - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Evaluation of Pain Management Efficacy Using Injectable Etoricoxib: Findings from the RAPID Study

  • By

  • Shiva Shankar Jha

  • Anoop Dhamangaonkar

  • Rajkumar Iyengar

  • Gautam Chakraverty

  • Kotini Saskar Rao

  • Abhijeet Mukherji

  • Sameer Muchhala

  • Vidhya Natarajan

  • August 22, 2026

Share

  • 1

    The RAPID study evaluated the efficacy of intramuscular etoricoxib 90 mg for acute pain management across 68 sites in India.

  • 2

    Patients receiving intramuscular etoricoxib experienced significant pain reduction within 60 minutes, lasting up to 24 hours.

  • 3

    Intramuscular etoricoxib was generally well tolerated, with few reported side effects, indicating its potential for acute pain management.

  • 4

    The study aimed to assess pain intensity changes using the Numeric Pain Rating Scale and evaluate tolerability through adverse events.

  • 5

    Etoricoxib's injectable formulation addresses the need for effective pain relief when oral medications are impractical or contraindicated.

Original Source(s)

Related Content